We found that treatment with Exos significantly facilitated tumour growth (Figure S7A–C), glucose consumption (Figure S7D) and lactate production (Figure S7E) in tumours, which were abolished by KLF13 overexpression. The gene discussed is KLF13; the disease is neoplasm.